Protection against Shiga Toxins.
Kavaliauskiene S, Dyve Lingelem AB, Skotland T, Sandvig K.
Toxins (Basel). 2017 Feb 3;9(2):44. doi: 10.3390/toxins9020044.
[Toxic bacillary dysentery and amaurosis (author's transl)].
Tong Y.
Zhonghua Yan Ke Za Zhi. 1979;15(4):295-6.
Shiga toxins and apoptosis.
Cherla RP, Lee SY, Tesh VL.
FEMS Microbiol Lett. 2003 Nov 21;228(2):159-66. doi: 10.1016/S0378-1097(03)00761-4.
Trimethoprim-sulfamethoxazole in the United States.
Wormser GP, Keusch GT.
Ann Intern Med. 1979 Sep;91(3):420-9. doi: 10.7326/0003-4819-91-3-420.
[Anisodamine in the treatment of severe toxic bacillary dysentery].
[No authors listed]
Zhonghua Yi Xue Za Zhi. 1973;8:492-3.
Targeting the Early Endosome-to-Golgi Transport of Shiga Toxins as a Therapeutic Strategy.
Li D, Selyunin A, Mukhopadhyay S.
Toxins (Basel). 2020 May 22;12(5):342. doi: 10.3390/toxins12050342.
Evaluation of anti-biofilm, anti-quorum, anti-dysenteric potential of designed polyherbal formulation: in vitro and in vivo study.
Singh D, Singh V, Bhushan Mishra S, Sharma D, Agarwal V.
J Appl Biomed. 2022 Mar;20(1):7-14. doi: 10.32725/jab.2022.005. Epub 2022 Mar 16.
Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology.
Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW, Peng W, Yang XB.
Pharm Biol. 2019 Dec;57(1):193-225. doi: 10.1080/13880209.2019.1577466.
Shiga toxin--an expanding role in the pathogenesis of infectious diseases.
Cantey JR.
J Infect Dis. 1985 May;151(5):766-71. doi: 10.1093/infdis/151.5.766.
Potentially lethal complications of shigellosis.
Bennish ML.
Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S319-24. doi: 10.1093/clinids/13.supplement_4.s319.
